Skip to content
10-Q

Quarterly Report

TRIUS THERAPEUTICS INC

0001193125-13-324372

← back to feed
Filed
Aug 7, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2013 · Aug 1, 2013 48.27M sh
Capex Q2 2013 · Jun 30, 2013 $202K
Capex Q2 2013 · Jun 30, 2012 $221K
Operating Cash Flow Q2 2013 · Jun 30, 2013 −$28.43M
Operating Cash Flow Q2 2013 · Jun 30, 2012 −$23.47M
Cash And Equivalents Q2 2013 · Jun 30, 2013 $15.32M
Cash And Equivalents Q2 2013 · Dec 31, 2012 $16.37M
Cash And Equivalents Q2 2013 · Jun 30, 2012 $13.51M
Cash And Equivalents Q2 2013 · Dec 31, 2011 $11.38M
Current Liabilities Q2 2013 · Jun 30, 2013 $19.38M
Current Liabilities Q2 2013 · Dec 31, 2012 $18.49M
Current Assets Q2 2013 · Jun 30, 2013 $72.92M
Current Assets Q2 2013 · Dec 31, 2012 $73.98M
Total Assets Q2 2013 · Jun 30, 2013 $74.06M
Total Assets Q2 2013 · Dec 31, 2012 $75.27M
Sga Expense Q2 2013 · Jun 30, 2013 $5.54M
Sga Expense Q2 2013 · Jun 30, 2013 $10.05M
Sga Expense Q2 2013 · Jun 30, 2012 $3.31M
Sga Expense Q2 2013 · Jun 30, 2012 $6.32M
Rd Expense Q2 2013 · Jun 30, 2013 $14.68M
Rd Expense Q2 2013 · Jun 30, 2013 $27.23M
Rd Expense Q2 2013 · Jun 30, 2012 $16.38M
Rd Expense Q2 2013 · Jun 30, 2012 $33.23M
Net Income Q2 2013 · Jun 30, 2013 −$19.68M
Net Income Q2 2013 · Jun 30, 2013 −$36.96M
Net Income Q2 2013 · Jun 30, 2012 −$14.41M
Net Income Q2 2013 · Jun 30, 2012 −$22.02M
Operating Income Q2 2013 · Jun 30, 2013 −$18.94M
Operating Income Q2 2013 · Jun 30, 2013 −$34.26M
Operating Income Q2 2013 · Jun 30, 2012 −$13.47M
Operating Income Q2 2013 · Jun 30, 2012 −$23.48M
Revenue Q2 2013 · Jun 30, 2013 $1.29M
Revenue Q2 2013 · Jun 30, 2013 $3.02M
Revenue Q2 2013 · Jun 30, 2012 $6.22M
Revenue Q2 2013 · Jun 30, 2012 $16.06M